An elevated magnitude of FANCD2 expression, concomitant with the unfavorable prognostic outlook of patients, has been detected in cases of endometrial cancer [14], hepatocellular carcinoma [15] and ovarian carcinomas [16]. Here, FANCD2 is linked to hepatocellular carcinoma.